CINECA IRIS Institutional Research Information System

SALAROGLIO, Iris Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.707
EU - Europa 1.889
AS - Asia 1.846
AF - Africa 46
SA - Sud America 31
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.545
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.618
CN - Cina 1.028
IT - Italia 699
SG - Singapore 290
SE - Svezia 184
AT - Austria 165
IE - Irlanda 165
HK - Hong Kong 132
FR - Francia 129
DE - Germania 109
JP - Giappone 92
GB - Regno Unito 79
TW - Taiwan 55
UA - Ucraina 54
FI - Finlandia 52
ID - Indonesia 51
CA - Canada 50
PL - Polonia 50
IN - India 41
MX - Messico 39
VN - Vietnam 36
BE - Belgio 32
ES - Italia 30
KR - Corea 29
NL - Olanda 25
AU - Australia 21
EG - Egitto 20
IR - Iran 20
TR - Turchia 19
PT - Portogallo 18
DK - Danimarca 16
CH - Svizzera 14
CZ - Repubblica Ceca 14
GR - Grecia 14
RU - Federazione Russa 13
BR - Brasile 10
SN - Senegal 9
NO - Norvegia 8
HU - Ungheria 7
AR - Argentina 6
CL - Cile 6
MA - Marocco 6
PK - Pakistan 6
RO - Romania 6
TH - Thailandia 6
CO - Colombia 5
MO - Macao, regione amministrativa speciale della Cina 5
AM - Armenia 4
BD - Bangladesh 4
IL - Israele 4
IQ - Iraq 4
MY - Malesia 4
NG - Nigeria 4
UZ - Uzbekistan 4
PH - Filippine 3
BQ - ???statistics.table.value.countryCode.BQ??? 2
EC - Ecuador 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
MU - Mauritius 2
PE - Perù 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EU - Europa 1
JO - Giordania 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
TG - Togo 1
TN - Tunisia 1
Totale 6.545
Salva come PNG Salva come JPEG
Città #
Chandler 252
Singapore 206
Torino 206
Santa Clara 192
Beijing 189
Fairfield 166
Ashburn 165
Dublin 161
Vienna 159
Houston 113
Turin 109
Woodbridge 99
Ann Arbor 94
Wilmington 77
Seattle 75
Guangzhou 66
Dearborn 64
Cambridge 61
Nyköping 58
New York 52
Pisa 48
Columbus 46
Jakarta 45
Nanjing 45
Shanghai 45
Redwood City 44
Hangzhou 43
Princeton 38
Central 37
Taipei 37
Medford 31
Fremont 30
Helsinki 30
Milan 29
Villeurbanne 28
Warsaw 26
Changsha 24
Tokyo 24
Wuhan 24
Hong Kong 23
Jacksonville 23
Boston 21
Brussels 21
Boardman 20
Los Angeles 20
Chengdu 18
Dong Ket 18
London 18
Shenzhen 18
San Jose 17
Paris 16
Chongqing 15
Jinan 15
San Diego 15
Tianjin 15
Toronto 15
Frankfurt am Main 14
Shenyang 14
Xian 13
Buffalo 12
Rome 12
Brno 11
Cairo 11
Las Vegas 11
Brescia 10
Central District 10
Chicago 10
Osaka 10
Ottawa 10
Seoul 10
Dallas 9
Hebei 9
Kunming 9
Nuremberg 9
Changchun 8
Fuzhou 8
Hefei 8
San Francisco 8
Suzhou 8
Harbin 7
Istanbul 7
Mexico 7
Mumbai 7
San Giuliano Milanese 7
Silver Spring 7
Xi'an 7
Athens 6
Barcelona 6
Bethesda 6
Camporosso 6
Dalian 6
Detroit 6
Florence 6
Hamburg 6
Heidelberg 6
Kharkiv 6
Lexington 6
Nanning 6
Piemonte 6
Porto 6
Totale 3.913
Salva come PNG Salva come JPEG
Nome #
Impact of cancer metabolism on therapy resistance – Clinical implications 721
Hypoxia as a driver of resistance to immunotherapy 673
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment 472
Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3-signalling. 301
Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 295
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 271
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma 268
PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy 264
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 257
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer 180
The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma 173
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma 150
The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells. 149
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer 140
Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment 135
Temozolomide down-regulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/GSK3/β-catenin pathway 129
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells 128
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells 124
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 117
P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors 111
New tetrahydroisoquinoline derivatives overcome pgp activity in brain-blood barrier and glioblastoma multiforme in vitro 111
Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells 110
Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution 108
Novel lymphocyte-independent antitumor activity by PD-1 blocking antibody against PD-1+ chemoresistant lung cancer cells 96
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons 92
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection 84
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 81
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance? 77
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma 76
GIFC-2018 - BOOK OF ABSTRACTS 75
Temozolomide epigenetically down-regulates Wnt3a-dependent signaling and P- glycoprotein in glioblastoma stem cells 74
Plant-Derived Trans-β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation 73
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 71
Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma 70
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 70
Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer 51
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer 45
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer 39
Naked and Decorated Nanoparticles Containing H2S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells 35
Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression 31
Dysregulation of FLVCR1a-dependent mitochondrial calcium handling in neural progenitors causes congenital hydrocephalus 25
Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors 23
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma 19
Thermomagnetic Resonance Effect of the Extremely Low Frequency Electromagnetic Field on Three-Dimensional Cancer Models 18
Human and canine osteosarcoma cell lines: How do they react upon incubation with calcium phosphate-coated lipid nanoparticles carrying doxorubicin and curcumin? 17
Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition 15
Increasing membrane polyunsaturated fatty acids sensitizes non-small cell lung cancer to anti-PD-1/PD-L1 immunotherapy 14
Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs 12
A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compound 10
Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro 10
The blood-brain barrier/glioblastoma stem cells interaction is a key factor determining tumor chemoresistance: new therapeutic strategies to improve the pharmacological treatment of glioblastoma multiforme 5
Smart hyaluronated micelles to enhance a gemcitabine prodrug efficacy 2
Totale 6.697
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.843
article - articoli 0
book - libri 0
conference - conferenze 1.363
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.206
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020502 0 0 0 0 0 83 81 65 71 77 64 61
2020/2021789 35 75 47 65 83 72 51 57 60 85 84 75
2021/2022742 54 31 34 90 30 33 41 43 33 62 167 124
2022/20231.175 92 74 51 92 117 205 98 100 139 54 60 93
2023/20241.277 115 129 92 104 82 160 125 88 38 126 107 111
2024/20251.041 64 130 118 162 424 143 0 0 0 0 0 0
Totale 6.697